Clinical and Laboratory Characteristics of Diabetic COVID-19 Patients with High Risk of Mortality: A Single-Center Study from Central India
DOI:
https://doi.org/10.47203/IJCH.2024.v36i06.023Keywords:
Diabetes Mellitus, COVID-19, Clinical Characteristics, Laboratory characteristics, MortalityAbstract
Background: Diabetes is a common comorbidity and risk factor of mortality in COVID-19 in India but data on characteristics of diabetic COVID-19 is scarce. Objectives: We aimed to study clinical and laboratory characteristics, and mortality of diabetic COVID-19 patients. Methods: This study included 235 COVID-19 patients presenting to our Center, from February, 2021 to May 2022. The demographics, clinical features, laboratory results were collected from the hospital records. Results: Out of 235 eligible COVID-19 patients, 107 (45.5%) were diabetic and 128 (54.5%) were non-diabetic. The diabetics compared to non-diabetics had higher frequency of hypertension (62.6% vs 34.4%; p<0.001), cardiovascular disease (8.4% vs 1.5%; p<0.05) and mortality (27.1% vs 13%; p<0.001). D-dimer (8.9+3.1 vs 1.2+ 5.1; p<0.01), CRP (269.2+136.0 vs 49.8 + 63.4; p<0.001), neutrophils (10.6 vs 7.2; <0.001], HbA1c (8.3 + 1.6 vs 5.2± 0.5%; p<0.05) and Troponin-T (1.8+17.6 vs 0.02 +1.2; <0.05) were higher while AST (48.9+79.6 vs 77.0+88.4; p<0.01) and lymphocytes (0.9 vs 1.3); <0.01) were lower in diabetics than non-diabetics. Mortlaity in diabetics was associated with hypertension (p<0.01), cardiovascular disease (p<0.001) and elevated D-dimer (p<0.0001) and neutrophils (p<0.05) but lower lymphocyte counts (p<0.001). Conclusion: The diabetic COVID-19 patients had higher mortality associated with hypertension, cardiovascular disease, elevated D-dimer, neutrophilic leukocytosis and lymphocytopenia.
Downloads
References
Kapoor M, Kaur KN, Saeed S, Shannawaz M, and Chandra A. Impact of COVID-19 on healthcare system in India: A system-atic review. J Public Health Res. 2023; 12: 22799036231186349.
Stirparo G, Oradini-Alacreu A, Migliori M , Villa GF, Botteri M , Fagoni N , Signorelli C , Sechi GM, Zoli A.Public health impact of the COVID-19 pandemic on the emergency healthcare system. J Public Health (Oxf). 2022; 44: e149-e152.
WHO Director-General's opening remarks at the media briefing on COVID-19: March 11, 2020. Available at: www.who.int/director-general. Accessed on 15/12/24.
World Health Organization (WHO), Coronavirus Disease (COVID-19) Pandemic Dashboard. Available at: www.who.int/emergencies/diseases/novel coronavirus 2019. Accessed on 31/12/24.
Adam D. COVID's true death toll: much higher than official records. Nature. 2022; 603: 562.
Moftakhar L, Moftakhar P, Piraee E, Ghaem H, Valipour A, Azarbakhsh H. Epidemiological characteristics and outcomes of COVID-19 in diabetic versus non-diabetic patients. Int J Diabetes Dev Ctries. 2021; 41: 383-388.
Goyal A, Gupta Y, Kalaivani M, Praveen PA, Ambekar S , and Tandon N. SARS-CoV-2 Seroprevalence in Individuals With Type 1 and Type 2 Diabetes Compared With Controls. En-docr Pract. 2022; 28:191-198.
Kumar A , l Arora A , Sharma P , Anikhindi SA , Bansal N , Singla V , Khare S , and Srivastava A. Is diabetes mellitus as-sociated with mortality and severity of COVID 19? A meta-analysis. Diabetes Metab Syndr. 2020; 14: 535-545.
Sharma P, Behl T, Sharma N, Sing S, Grewal AS, Albarrati A, Albratty M, Meraya AM, and Bungau S. COVID-19 and dia-betes: Association intensify risk factors for morbidity and mortality. Biomed Biopharmacother. 2022; 151: 113089.
Zhu L, She Z-G, Cheng X, Qin J-J, Zhang X-J, Cai J, et al. Asso-ciation of blood glucose control and outcomes in patients with COVID-19 and pre-existing type-2 diabetes. Cell Metabol. 2020;31: 1068-77
Jindal R, Gupta M, Khan FR, and Gunjan Chaudhry G. Preva-lence of co morbidities and its association with mortality in Indian patients with COVID 19: A meta analysis. Indian J Anaesth, 2022; 66: 399-418.
Gupta A, Nayan N, Nair R, Kumar K, Joshi A, Sharma S, Singh J, and Kapoor R. Diabetes Mellitus and Hypertension Increase Risk of Death in Novel Corona Virus Patients Irre-spective of Age: a Prospective Observational Study of Co-morbidities and COVID-19 from India. SN Compr Clin Med. 2021; 3: 937-944.
Bailly L, Fabre R, Courjon J , Carls M, Dellamonica J and Pradier C. Obesity, diabetes, hypertension and severe out-comes among inpatients with coronavirus disease 2019: a nationwide study. Clin Microbiol Infect. 2022; 28: 114-123.
Hussain S, Baxi H, Jamali MC, Nisar N, Hussain MS. Burden of diabetes mellitus and its impact on COVID-19 patients: A me-ta-analysis of real-world evidence. Diabetes Metab Syndr. 2020; 14:1595-1602.
Roy DB, Gupta V Tomar S, Gupta G, Biswas A, Ranjan P, Baitha U, Pandey S, Prakash B, and Wig N. Epidemiology and Risk Factors of COVID-19- Related Mortality. Cureus. 2021; 13: e20072.
Wu Z, McGoogan JM. Characteristics of and important les-sons from the coronavirus disease 2019 (COVID-19) out-break in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. J Am Med Assoc. 2020; 323: 1239-1242.
Nair AM, Gopalan S, Rajendran V, Varadaraj P, Marappa L, Pandurangan V, Madhavan S, Mani R, and Bhaskar E. Role of secondary sepsis in COVID-19 mortality: Observations on patients with preexisting diabetes mellitus and newly diag-nosed hyperglycemia. Monaldi Arch Chest Dis. 2022; 92: 2037. doi: 10.4081/monaldi.2022.2037.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395: 1054-1062.
Hardy YH, Libhaber E, Ofori E, Amenuke DAY, Kontoh SA, Dankwah JA, Larsen-Reindorf R, Otu-Ansah C Hutton-Mensah K, Dadson E, Adamu S, Akyerekoh K, Sarfo FS, and Nkum B. Clinical and laboratory profile and outcomes of hospitalized COVID-19 patients with type 2 diabetes melli-tus in Ghana – A single-center study. Endocrinol Diab Metab. 2023; 6: e391.
Li G , Deng Q, Feng J , Li F ,Xiong N , and He Q. Clinical Characteristics of COVID-19 Patients with and without Diabe-tes in Wuhan Red Cross Hospital. J Diabetes Res. 2020; 2020: 1652403.
Akbariqomi M , Hosseini MS , Rashidiani J , Sedighian H, Biganeh H , Heidari R , Moghaddam MM, Farnoosh G , and Kooshki H. Clinical characteristics and outcome of hospital-ized COVID-19 patients with diabetes: A single-center, retro-spective study in Iran. Diabetes Res Clin Pract. 2020; 169: 108467.
Zhang Q , Wei Y, Chen M, Wan Q, and Chen X. Clinical analy-sis of risk factors for severe COVID-19 patients with type 2 diabetes. J Diabetes Complications. 2020; 34: 107666.
Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y, et al. Comor-bidity and its impact on 1590 patients with Covid-19 in Chi-na: A nationwide analysis. Eur Respir J. 2020; 55: 2000547. doi.org/10.1183/13993003.00547-2020.
Dallavalasa S , Tulimilli SV, Prakash J, Ramachandra R, Madhunapantula SV, and Veeranna RP. COVID-19: Diabetes Perspective—Pathophysiology and Management. Pathogens. 2023; 12:184.
Downloads
Published
How to Cite
License
Copyright (c) 2024 Jaya Jain, Nidhi Tripathy , Ashutosh Jain
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
